Actively Recruiting
Genotype-Phenotype Correlation in Patients With Chromosome 9P Minus Syndrome
Led by Washington University School of Medicine · Updated on 2024-08-05
200
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
W
Washington University School of Medicine
Lead Sponsor
D
Dickson, Patricia I., M.D.
Collaborating Sponsor
AI-Summary
What this Trial Is About
This research focuses on patients with a rare condition called Chromosome 9P Deletion Syndrome, where a part of chromosome 9 is missing. Because only about 200 cases have been reported in medical literature, the study aims to better understand the link between the specific deleted genes and the diverse physical traits seen in affected individuals. Researchers will use advanced genome sequencing techniques to analyze the size and location of the chromosome deletion and examine the genetic background of each patient. Participants will undergo whole genome sequencing to gather detailed genetic information. Alongside this, they will complete a thorough questionnaire and provide a biospecimen sample for analysis. Family members, such as parents and siblings, may also participate to help clarify how genetic background influences physical characteristics related to the condition. During the study, participants will provide medical information through questionnaires and biospecimens, which researchers will use to identify correlations between genetic changes and physical traits. The main outcome measured is the relationship between genotype and phenotype, with preliminary results expected as enrollment increases. The study is observational, and participants' involvement will mainly consist of providing samples and information for research purposes.
CONDITIONS
Brief Title
Chromosome 9 P Minus Syndrome
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of 9P minus syndrome or deletions on the 9th chromosome
- Parents and siblings of affected individuals may participate to study genetic background contributions
You will not qualify if you...
- There are no exclusion criteria for affected individuals or their family members
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 5 years
Participants undergo assessments to study genetic and phenotypic characteristics related to Chromosome 9P Minus Syndrome.
Visits as needed depending on study assessments
Trial Site Locations
Total: 1 location
1
Washington University School of Medicine
St Louis, Missouri, United States, 63110
Actively Recruiting
Research Team
F
F. S. Cole, M.D.
S
Sophia Couteranis
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here